Cryoprecipitate is a blood product derived from plasma. It is concentrated with specific proteins, primarily including von Willebrand factor (vWF), fibrinogen, Factor VIII, and Factor XIII.
The suitability of cryoprecipitate for treating various conditions depends on its concentrated components:
Based on the composition of cryoprecipitate, it is not indicated for the treatment of Hemophilia B.
Conclusion: Hemophilia B cannot be treated with cryoprecipitate.A young primigravida with 11 weeks pregnancy presents with sudden onset pain and swelling of left lower limb. Homan's sign is positive. Duplex ultrasonogram shows non- compressibility of veins in the affected region, with absent flow. The drug of choice for treatment is:
A female carrier for hemophilia A gene gets married to a genetically normal male. What are the chances of her delivering a male offspring with hemophilia?